UBS AG - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 36 filers reported holding ANI PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$72,000
+242.9%
2,540
+311.7%
0.00%
Q2 2014$21,000
-95.6%
617
-96.0%
0.00%
Q1 2014$482,000
+342.2%
15,394
+184.3%
0.00%
Q4 2013$109,000
+1716.7%
5,414
+735.5%
0.00%
Q3 2013$6,0006480.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 200,000$13,270,00021.02%
Healthcare Value Capital, LLC 50,000$3,318,0005.26%
Consonance Capital Management LP 653,258$43,344,0004.17%
1492 Capital Management LLC 34,500$2,289,0001.87%
JW Asset Management, LLC 29,722$1,972,0001.36%
FRANKLIN STREET ADVISORS INC /NC 29,000$1,924,0000.35%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 55,705$3,696,0000.27%
Ativo Capital Management LLC 15,805$1,049,0000.24%
DIKER MANAGEMENT LLC 9,810$651,0000.23%
CASTLEARK MANAGEMENT LLC 100,615$6,676,0000.20%
View complete list of ANI PHARMACEUTICALS INC shareholders